ONTXW - Onconova Therapeutics Inc - Warrants (01/08/2021)
Previous close
0.0671
0 0%
Share volume: 415,931
Last Updated: Fri 23 Jul 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
Fundamental analysis
57%
Profitability
68%
Dept financing
0%
Liquidity
0%
Performance
75%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Company detail
CEO: Steven Fruchtman
Region: US
Website: www.onconova.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: www.onconova.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.
Recent news